News | October 31, 2011

Lantheus Awarded Supplier Agreement with Premier for Radiopharmaceutical Products

October 31, 2011 –Lantheus Medical announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, the group purchasing unit of the Premier healthcare alliance, for its radiopharmaceutical imaging agents.

Effective Jan. 1, 2012 through Dec. 31, 2014, the new radiopharmaceutical products agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Cardiolite (kit for the preparation of Technetium Tc99m Sestamibi for injection), Gallium 67 (Gallium Citrate Ga67 injections), Neurolite (kit for the preparation of Technetium Tc99m Bicisate for Injection), TechneLite (Technetium Tc99m generator), 201 Thallium (Thallous Chloride Tl201 Injection) and Xenon 133 (Xenon Xe 133 gas).

Lantheus’ radiopharmaceutical products will be offered through a specially negotiated contract to more than 2,500 hospitals nationwide and 76,000-plus healthcare sites. The contract was awarded after a competitive bidding process that examined multiple factors, including pricing and clinical experience with the diagnostic imaging agents, as well as Lantheus’ support of the products.

Please visit www.lantheus.com

Related Content

News | Radiopharmaceuticals and Tracers

August 2, 2019 — The American Society of Radiologic Technologists (ASRT) announced its support for House Resolution (HR) ...

Home August 02, 2019
Home
News | Radiopharmaceuticals and Tracers

July 16, 2019 – NorthStar Medical Radioisotopes LLC announced completion of construction on its 20,000-square-foot ...

Home July 16, 2019
Home
News | Radiopharmaceuticals and Tracers

June 5, 2019 – BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), introduced a novel ...

Home June 05, 2019
Home
News | Radiopharmaceuticals and Tracers

May 17, 2019 — Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular ...

Home May 17, 2019
Home
News | Radiopharmaceuticals and Tracers | Jeff Zagoudis, Associate Editor

May 10, 2019 — Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in ...

Home May 10, 2019
Home
News | Radiopharmaceuticals and Tracers

October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc. (CORAR) — the voice of the radionuclide ...

Home October 12, 2018
Home
Feature | Radiopharmaceuticals and Tracers | Dave Fornell

February 8, 2018 — The U.S. Food and Drug Administration (FDA) and the Nuclear Regulatory Commission (NRC) recently took ...

Home February 26, 2018
Home
News | Radiopharmaceuticals and Tracers

August 30, 2017 — ARTMS Products Inc. signed a strategic partnership with GE Healthcare around ARTMS’ proprietary ...

Home August 30, 2017
Home
News | Radiopharmaceuticals and Tracers

May 22, 2017 — Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the ...

Home May 22, 2017
Home
News | Radiopharmaceuticals and Tracers

April 28, 2017 — Researchers at the Australian Nuclear Science and Technology Organisation (ANSTO) have led the ...

Home April 28, 2017
Home
Subscribe Now